Navigation Links
DecisionQ Partners With Thomas Jefferson University to Reveal Insights for Cancer Therapy

Partnership integral piece of consortium recently awarded five-year, $6.7 million Susan G. Komen for the Cure Promise Grant

WASHINGTON, April 29 /PRNewswire/ -- Thomas Jefferson University's Kimmel Cancer Center has partnered with DecisionQ, a leader in predictive analytics and machine learning to uncover life-saving answers hidden in the center's proprietary and extensive cancer registries. DecisionQ will leverage its expertise in developing predictive algorithms to identify how patients will respond to different therapeutic options for breast and colon cancers.

The team is part of a consortium that was recently awarded a Susan G. Komen for the Cure Promise Grant of nearly $6.7 million for five years of continued breast cancer research. Promise grants support multi-disciplinary research with the greatest potential to significantly reduce breast cancer incidence and/or mortality within the next decade.

"Identification of therapy-relevant biomarkers is a crucial part of breast cancer research, as there are many different biomarkers that could predict treatment response and outcome, and serve as targets for treatment," said Hallgeir Rui, M.D., Ph.D., professor of Cancer Biology at Thomas Jefferson University. "DecisionQ's Faster AnalyticsTM will be used to further refine the team's predictive models in breast cancer, helping us to identify protein biomarker patterns that can be used to make sure patients are offered the most appropriate therapy."

Leading experts in the fields of decision analysis, statistics and machine learning have developed the technology and approach that DecisionQ applies in creating MMIA's (multi marker interpretive assays), greatly enhancing the quality of human judgment in an interactive, real-time environment at a low marginal cost.

"More than a million new cancer diagnoses are documented each year, giving researchers vast amounts of data with which to work," said Todd Radano, co-founder of DecisionQ. "Applying advances in analytics via machine learning will assist scientists in taking what is known about the disease and developing actionable insights that could ultimately save lives."

About DecisionQ Corporation

DecisionQ is a leader in predictive analytics and machine learning technologies with expertise in the healthcare, life sciences, financial services and security industries. Through the application of its advanced technologies and methods it delivers customers substantial improvements in the speed and quality of decision making by allowing them to quickly turn data into actionable insights. To learn more about DecisionQ visit

                                         Laura Phillips, Vehr Communications

SOURCE DecisionQ Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. E&K Scientific Announces Partnership with Sciformatix
2. PRA International Presents Key Budgeting Strategies at 18th Annual CRO Partnerships Conference
3. Isis and Partners Present New Research at the American Association for Cancer Research 2009 Annual Meeting
4. Brazils top automakers to distribute 2 million copies of the Ethanol Handbook in partnership with the Brazilian Sugarcane Industry Association
5. Childrens Memorial Research Center, Chicago Becomes a Member of GeneGos MetaMiner Stem Cell Partnership Program
6. ViewRay Incorporated Closes $15M Tranche of Series B Financing and Announces Partnership with Siemens AG
7. US Oncology Clinical Development Attends Partnerships With CROs
8. Aviation partners to cut 500,000 tonnes of CO2 a year
9. ChemImage and Next Breath Structure Partnership to Validate Bioequivalence Testing for Nasal Spray Suspensions
10. ACM Global Central Lab Announces Partnership with Chindexs United Family Hospitals in China
11. Van Andel Institute Joins the MetaMiner Oncology Partnership Program
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... ... will join the faculty of the University of North Carolina Kenan-Flagler Business ... strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on the school’s international ...
(Date:6/24/2016)... , June 24, 2016  Regular discussions on a ... take place between the two entities said Poloz. ... Ottawa , he pointed to the country,s ... the federal government. ... said, "Both institutions have common economic goals, why not sit ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle Marche ... with peritoneal or pleural mesothelioma. Their findings are the subject of a new article ... Diagnostic biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma patients ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/26/2016)... DUBLIN , April 27, 2016 ... of the  "Global Multi-modal Biometrics Market 2016-2020"  report ... ) , The analysts forecast ... a CAGR of 15.49% during the period 2016-2020.  ... a number of sectors such as the healthcare, ...
(Date:4/15/2016)... -- A new partnership announced today will help life ... a fraction of the time it takes today, ... insurance policies to consumers without requiring inconvenient and ... rapid testing (A1C, Cotinine and HIV) and higi,s ... pulse, BMI, and activity data) available at local ...
Breaking Biology News(10 mins):